BioCentury
ARTICLE | Top Story

FDA approves Dainippon's Latuda

October 29, 2010 12:55 AM UTC

FDA approved an NDA from Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) for Latuda lurasidone to treat schizophrenia. The company plans to launch the product next quarter. Latuda is a sma...